<DOC>
	<DOCNO>NCT02255045</DOCNO>
	<brief_summary>The investigator propose sustain vaginal administration would better response respect pain , good safety profile oral administration non-steroidal anti-inflammatory drug . Assess relief symptom associate dysmenorrhea specific survey elaborate also include Visual Analog Scale ( VAS ) make objective measure dysmenorrhea case McGill 's Pain Questionnaire ( MPQ ) .</brief_summary>
	<brief_title>Assess Vaginal Ring With Meloxicam Treatment Dysmenorrhea</brief_title>
	<detailed_description />
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Regular menstrual cycle previous 3 month ( 2435 day ) , Primary dysmenorrhea 3 previous month , With tubal ligation user condom contraception , Hemoglobin least 11 g/dl , Safety blood analysis normal level Secondary dysmenorrhea , Users hormonal contraceptive ( 2 month prior study ) IUDs ( intrauterine device ) ( 1 month prior study ) . Allergy anti inflammatory drug include meloxicam diclofenac . Allergy silicon . Pregnant lactation . Women untreated decompensated endocrine disorder</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>